コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 merous reasons why errors and adverse events should be disclosed, and use of a standard framework for
4 nfluence trial outcomes, placebo formulation should be disclosed in reports of placebo-controlled tri
5 nizing radiation during an imaging procedure should be disclosed to all patients by the ordering prov
6 eported that potential conflicts of interest should be disclosed to patients on research trials (52%
8 elines, the allowable uses of GAI and how it should be disclosed varied substantially, with this hete